Kinetics of the IgG antibody response to pertussis toxin after infection with B-pertussis

被引:52
作者
Teunis, PFM
Van der Heijden, OG
De Melker, HE
Schellekens, JFP
Versteegh, FGA
Kretzschmar, MEE
机构
[1] Natl Inst Publ Hlth & Environm, Computerizat & Methodol Consultancy Unit, NL-3720 BA Bilthoven, Netherlands
[2] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Epidemiol, NL-3720 BA Bilthoven, Netherlands
[3] Natl Inst Publ Hlth & Environm, Lab Infect Dis Screening, NL-3720 BA Bilthoven, Netherlands
[4] Groene Hart Ziekenhuis, Dept Pediat, Gouda, Netherlands
关键词
D O I
10.1017/S0950268802007896
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We aimed to provide a quantitative description of decay in pertussis antibody levels to aid in finding a serological estimate of the incidence of pertussis. The serum IgG response against pertussis toxin was studied in a group of clinically diagnosed patients. Individual records consisted of repeated serum IgG measurements at irregular intervals for up to 10 years post diagnosis. These data were analysed with a nonlinear regression model taking into account censoring at upper and lower threshold levels, measurement errors, and individual variation in the shape and magnitude of the immune response. There was considerable variation between individual responses, both in strength (amplitude) and duration (shape). The inverse model relating IgG levels to time from infection (diagnosis) can be applied to cross-sectional IgG data to generate distributions of times from infection, which may be used to calculate infection rates and their variation, in populations sampled for cross-sectional IgG data.
引用
收藏
页码:479 / 489
页数:11
相关论文
共 36 条
[1]   A hierarchical Bayesian model to predict the duration of immunity to Haemophilus influenzae type b [J].
Auranen, K ;
Eichner, M ;
Käyhty, H ;
Takala, AK ;
Arjas, E .
BIOMETRICS, 1999, 55 (04) :1306-1313
[2]  
Auranen K, 2000, STAT MED, V19, P281, DOI 10.1002/(SICI)1097-0258(20000215)19:3&lt
[3]  
281::AID-SIM344&gt
[4]  
3.0.CO
[5]  
2-D
[6]   Combined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccines for primary immunisation [J].
Bell, F ;
Martin, A ;
Blondeau, C ;
Thornton, C ;
Chaplais, J ;
Finn, A .
ARCHIVES OF DISEASE IN CHILDHOOD, 1996, 75 (04) :298-303
[7]   Reemergence of pertussis in the highly vaccinated population of the Netherlands:: Observations on surveillance data [J].
de Melker, HE ;
Schellekens, JFP ;
Neppelenbroek, SE ;
Mooi, FR ;
Rümke, HC ;
Conyn-van Spaendonck, MAE .
EMERGING INFECTIOUS DISEASES, 2000, 6 (04) :348-357
[8]   Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis [J].
de Melker, HE ;
Versteegh, FGA ;
Conyn-van Spaendonck, MAE ;
Elvers, LH ;
Berbers, GAM ;
van der Zee, A ;
Schellekens, JFP .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) :800-806
[9]  
DEMELKER HE, 1999, THESIS WAGENINGEN U
[10]   Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults [J].
DiTommaso, A ;
Bartalini, M ;
Peppoloni, S ;
Podda, A ;
Rappuoli, R ;
DeMagistris, MT .
VACCINE, 1997, 15 (11) :1218-1224